Target intelligence / Profile preview

MHC class I polypeptide-related sequence A and B (MICA/B)

Target
MICA/B
Molecular classification
MHC class I-like protein, Glycoprotein, Cell surface ligand
01

Overview

MHC class I polypeptide-related sequence A (MICA) and B (MICB), collectively known as MIC stress ligands, are cell surface glycoproteins that serve as primary ligands for the activating receptor NKG2D found on natural killer (NK) cells and certain T cells. Unlike classical MHC molecules, MICA/B do not present peptides but are instead upregulated in response to cellular stressors such as DNA damage, viral infection, or malignant transformation. In the context of oncology, many tumors attempt to evade immune detection by proteolytically shedding these ligands from their surface using metalloproteinases like ADAM10 and ADAM17. This shedding results in soluble MICA/B (sMICA/B), which can systemically downregulate NKG2D expression on immune cells, leading to immunosuppression. Therapeutic strategies currently under investigation include monoclonal antibodies designed to stabilize MICA/B on the cell surface by preventing shedding, thereby restoring the immune system's ability to recognize and eliminate malignant cells.

Other names
MIC stress ligandsMHC class I-related sequence AMHC class I-related sequence BStress-induced NKG2D ligandsMIC-AMIC-B
02

Mechanism of action

Prevention of proteolytic shedding of MICA/B from the tumor cell surface to maintain NKG2D-mediated immune surveillance and induction of antibody-dependent cellular cytotoxicity (ADCC).

03

Biological functions

Immune responseNatural killer cell activationT cell co-stimulationCellular stress signaling
04

Disease associations

CancerAutoimmune diseaseInfectionGraft-versus-host disease
05

Safety considerations

Potential for off-target autoimmunity if MICA/B are expressed on healthy stressed tissuesCytokine release syndrome in CAR-T applicationsImmune evasion through ligand shedding
06

Interacting drugs

7C6 (Anti-MICA/B antibody)

2 more in the full profile.

07

Biomarkers

Soluble MICA (sMICA) levelsSoluble MICB (sMICB) levelsSurface MICA/B expression on tumor biopsies

Beyond the preview

Go deeper on MHC class I polypeptide-related sequence A and B (MICA/B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MHC class I polypeptide-related sequence A and B (MICA/B).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call